Not exact matches
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and
other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger
than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the
Affordable Care Act or
other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over
other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or
other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and
other risks identified from
time to
time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Since less
than 20 percent of SMBs employ full -
time, dedicated IT employees, CMIT's services are an attractive and
affordable option for the
other 80 - plus percent.
While property is relatively more
affordable in
other parts of the country (six
times the average salary in the North - east rather
than 14
times in London) it's impossible to ignore that even in the most
affordable areas house prices are geared towards two - earner families with two or fewer children.
Winter produce are more
affordable than other fruits and vegetables this
time of year since they are in abundance
The U.S. Protection and
Affordable Care Act (PPACA), signed into law in 2010, requires employers to provide moms of babies younger
than 12 months a reasonable break
time for pumping and a private place to pump,
other than a bathroom.
The Housing Crisis
Affordable housing, a de Blasio campaign focus and administration legacy item, was brought up intermittently throughout the debate, at
times for longer stretches
than others.
The Nissan GT - R has a successful history of challenging
other supercars at a price point many
times more
affordable than its competitors, and the 2015 Nissan GT - R Nismo is no different.
We understand that from
time to
time people need a quick cash flow boost, to cover unexpected costs, and if you apply for your loan before 24 hours on business days you get it direct into your account, then in most cases the loan can be transferred the same day, Our low interest rates make us more
affordable than other personal loan providers in our market.
Starting at $ 254 per night (for one adult), the Element
Times Square is a more
affordable stay — and in this case it's more comfortable
than glamorous —
than some of Starwood's
other properties, which include The St. Regis and W hotels.
Because these plans only offer life insurance protection for a limited
time, they are going to be much more
affordable than other life insurance options.
Not only will an online search save you more
time, it will also likely provide more
affordable rates
than other methods of finding vehicle insurance quotes.
Most of the
time, a level term policies are much more
affordable for the coverage you get
than other term policies.